Back for its 21st meeting, The International Publication Planning Meeting (TIPPA) will be held as a virtual event on March 24-25. The conference will connect global stakeholders in biopharma, medical device/diagnostics, medical communication agencies, medical writers, and publishers for off-the-record discussion, networking, and idea exchange.
Throughout the two-day conference, TIPPA 2022, a live-streaming virtual event, will feature more than 20 industry speakers and 14 thought-provoking sessions. Here’s a look at five new features on this year’s agenda.
1. A keynote address kick-off
The conference will open with Kris Schuler, senior director, publications team leader, global scientific communications, Phizer Biopharmaceuticals Group, who will deliver a keynote address on the state of the profession and future of publication planning. Schuler will explore publication industry trends to prepare for post pandemic outcomes, how the role of publications professional will continue to evolve, and the current issues before the medical and scientific publications industry to shape frameworks that address needs and advance the industry in a positive direction.
2. A spotlight on diversity, equity, and inclusion
During a look at best practices for inclusivity and diversity in clinical trials, Shweta Rane, global medical director, Biogen, and Lauren Deluca, executive director & founding president, Chronic Illness Advocacy & Awareness Group, will discuss integration of patient data and perspectives into clinical development and data dissemination plans. They’ll also share how to best communicate with the patient community to drive the best and truly equitable results.
A panel, moderated by Lisa DeTora, associate professor and director of STEM writing, Hofstra University, will also explore authorship and inclusivity. Panelists will share perspectives on how to ensure inclusivity, equity, and diversity in your clinical trials continues through the publication process, tactics to bring diversity across the publication process, and next steps for policy development, transparency, and accessibility to enable transgender authors to correct their names in the published record.
3. ‘Choose Your Own Adventure’ breakouts
Both days of the conference will wrap with “Choose Your Own Adventure” breakouts where attendees will have the opportunity to turn on their cameras and mics and participate in up to three intimately sized discussion groups led by speakers. The roundtables will provide a space for attendees to address unique concerns and network with peers and TIPPA presenters.
Attendees will be able to choose from the following breakouts:
- The Future of Publication Planning facilitated by Payal Patel, senior director, medical communications and medical information, Genmab, and Doug Wicks, publication lead, specialty & primary Care (S&PC) publications GlaxoSmithKline
- Best Practices for Inclusivity and Diversity in Clinical Trials with Shweta Rane, global medical director, Biogen
- Finding Consensus on Enriched Content and PLS led by Monica Ramchandani, senior director, clinical development, medical writing and publications, Gilead Sciences
- Seizing Opportunities Beyond the Standard Clinical Trial Publication with Charlotte Singh, director, cardiovascular/established products publications lead, Sanofi US
- Authorship and Inclusivity led by Lisa DeTora, associate professor and director of STEM writing, Hofstra University
Day two breakouts will include:
- Ask the Editor led by rotating facilitators, including Leslie Citrome, clinical professor of psychiatry and behavioral sciences, New York Medical College, editor emeritus, International Journal of Clinical Practice; Kelly Soldavin, senior editor, Taylor & Francis; and Caroline Halford, digital publishing manager, Springer Healthcare
- AI and Publication Planning with Olle Bergman, international writing and scientific communications expert, Bergmans Bokstäver AB
- Infographics Best Practices led by Jamie Weiss, senior director, scientific programs, Prilenia
- New Technologies and Social Media led by Beth Carlton Tohill, clinical science liaison, WL Gore & Associates
- Putting Preprint Servers on Trial with Dustin Chernick, director of scientific communications, Gilead Sciences
4. An insightful roundtable discussion with journal editors
Leslie Citrome, clinical professor of psychiatry and behavioral sciences, New York Medical College, editor emeritus, International Journal of Clinical Practice will moderate a Journal Editors’ Hot Topics Roundtable where industry leaders will divulge what truly makes a standout difference when editors are looking at manuscripts and why they pass on some papers. The panel will also share tips for better journal targeting, triaging, and planning to boost the likelihood of your paper getting published as well as the funding issue at the base of the open access opportunity, and how to ensure a level playing field for academia, low to middle income countries, and others.
5. Strategies to thrive in 2022 and beyond
To prepare for future directions, DeTora, Rane, and Citrome will return to the virtual stage to highlight what’s new for 2022. They’ll focus on how upcoming innovations in good publications practice were developed, new developments in the field from multiple perspectives, and best practices for complying with April 2021 changes to the Consolidated Standards of Reporting Trials (CONSORT) guidelines.
In a special presentation, Olle Bergman, international writing and scientific communications expert, Bergmans Bokstäver AB, will explore how to live with the robots. He’ll discuss how to keep one pace ahead of artificial intelligence (AI) and prepare for change, how to prepare and put AI to best use, and how to survey alternatives to the present state of scientific publication to predict, shape, and prepare for the future.
A panel of industry experts from Janssen, WL Gore, Biosplice and Bristol Myers Squibb will also explore new technologies, social media, and the navigation of the digital world. Discussion points will include where various groups of professionals get their information, how that’s changed, and the implications of the trajectory; the evolution of where and how HCPs access and process information across generations to guide your plan and budget; best practices for integrating social media metrics and what the FDA guidance regarding who posts; and publication software options, trends, and benefits to better frame your cost benefit analysis for the switch.